Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CXCL13 antibody for the treatment of autoimmune disorders.
Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data.
Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.
Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study.
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Hepatocyte Growth Factor Limits Autoimmune Neuroinflammation via Glucocorticoid-Induced Leucine Zipper Expression in Dendritic Cells.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
What is new in MS spasticity research? Poster session highlights.
Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes.
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
[Consensus document on spasticity in patients with multiple sclerosis.]
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Vitamin D and multiple sclerosis.
New data identify an increasing sex ratio of multiple sclerosis in Sweden.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses.
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
Pages
« first
‹ previous
…
311
312
313
314
315
316
317
318
319
…
next ›
last »